SH
Stephen Hoge
President

Stephen Hoge insider trades: Moderna (MRNA) stock sales

President, Moderna Last trade Oct 15, 2026 170 Form 4 filings
$42.9M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
146
Open-market trades
since 2020
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephen reports to the SEC

Open-market buys and sales

146 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 15, 2026MRNA↓ Sell$17.0M
Sep 15, 2026MRNA↓ Sell$11.7M
Jul 15, 2026MRNA↓ Sell$3.6M
Jun 15, 2026MRNA↓ Sell$2.7M
Feb 23, 2026MRNA↓ Sell$7.8M
Dec 3, 2024MRNA↓ Sell$14K
Nov 29, 2024MRNA↓ Sell$12K
Nov 11, 2024MRNA↓ Sell$13K
Sep 3, 2024MRNA↓ Sell$24K
Aug 29, 2024MRNA↓ Sell$23K
Aug 12, 2024MRNA↓ Sell$21K
Jul 15, 2024MRNA↓ Sell$1.8M
Jun 17, 2024MRNA↓ Sell$2.1M
Jun 3, 2024MRNA↓ Sell$48K
May 29, 2024MRNA↓ Sell$49K
May 15, 2024MRNA↓ Sell$1.9M
May 10, 2024MRNA↓ Sell$31K
Apr 15, 2024MRNA↓ Sell$1.6M
Mar 15, 2024MRNA↓ Sell$1.5M
Mar 4, 2024MRNA↓ Sell$29K
Feb 29, 2024MRNA↓ Sell$226K
Feb 22, 2024MRNA↓ Sell$1.5M
Feb 16, 2024MRNA↓ Sell$937K
Feb 12, 2024MRNA↓ Sell$26K
Jan 16, 2024MRNA↓ Sell$1.6M
Dec 27, 2023MRNA↓ Sell$4.5M
Dec 4, 2023MRNA↓ Sell$25K
Nov 29, 2023MRNA↓ Sell$91K
Nov 10, 2023MRNA↓ Sell$18K
Sep 15, 2023MRNA↓ Sell$1.7M
Sep 5, 2023MRNA↓ Sell$36K
Aug 29, 2023MRNA↓ Sell$131K
Aug 17, 2023MRNA↓ Sell$1.5M
Aug 10, 2023MRNA↓ Sell$25K
Jul 17, 2023MRNA↓ Sell$1.8M
Jun 15, 2023MRNA↓ Sell$1.9M
Jun 2, 2023MRNA↓ Sell$40K
May 30, 2023MRNA↓ Sell$148K
May 10, 2023MRNA↓ Sell$33K
Mar 2, 2023MRNA↓ Sell$161K
Mar 1, 2023MRNA↓ Sell$148K
Feb 10, 2023MRNA↓ Sell$40K
Nov 29, 2022MRNA↓ Sell$189K
Nov 10, 2022MRNA↓ Sell$38K
Sep 13, 2022MRNA↓ Sell$977K
Aug 29, 2022MRNA↓ Sell$152K
Aug 24, 2022MRNA↓ Sell$1.4M
Aug 15, 2022MRNA↓ Sell$1.7M
Aug 10, 2022MRNA↓ Sell$42K
Jul 25, 2022MRNA↓ Sell$1.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MRNA insiders

Open-market trades in the last 12 months

About Stephen Hoge's insider trades

Stephen Hoge is President at Moderna (MRNA). Since Jan 13, 2020, Stephen has reported no open-market purchases and 146 sales worth $338.7M on SEC Form 4. In the last 12 months: 5 sales ($42.9M).

Their filings also include option exercises (134 filings), shares withheld for taxes (15 filings), grants and awards (13 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.